Abeona Net Debt from 2010 to 2026
| ABEO Stock | USD 4.99 0.07 1.38% |
Net Debt | First Reported 1995-12-31 | Previous Quarter -139.5 M | Current Value -59.1 M | Quarterly Volatility 29.1 M |
Check Abeona Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abeona Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Interest Expense of 5.1 M or Selling General Administrative of 25.5 M, as well as many indicators such as Price To Sales Ratio of 33.43, Dividend Yield of 6.5 K or PTB Ratio of 5.8. Abeona financial statements analysis is a perfect complement when working with Abeona Therapeutics Valuation or Volatility modules.
Abeona | Net Debt | Build AI portfolio with Abeona Stock |
Evaluating Abeona Therapeutics's Net Debt across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Abeona Therapeutics's fundamental strength.
Latest Abeona Therapeutics' Net Debt Growth Pattern
Below is the plot of the Net Debt of Abeona Therapeutics over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Abeona Therapeutics' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abeona Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Debt | 10 Years Trend |
|
Net Debt |
| Timeline |
Abeona Net Debt Regression Statistics
| Arithmetic Mean | (23,917,241) | |
| Coefficient Of Variation | (183.83) | |
| Mean Deviation | 31,608,122 | |
| Median | (3,865,000) | |
| Standard Deviation | 43,967,274 | |
| Sample Variance | 1933.1T | |
| Range | 149M | |
| R-Value | 0.04 | |
| Mean Square Error | 2058.2T | |
| R-Squared | 0 | |
| Significance | 0.87 | |
| Slope | 374,800 | |
| Total Sum of Squares | 30929.9T |
Abeona Net Debt History
Other Fundumenentals of Abeona Therapeutics
Abeona Therapeutics Net Debt component correlations
Click cells to compare fundamentals
About Abeona Therapeutics Financial Statements
Abeona Therapeutics investors utilize fundamental indicators, such as Net Debt, to predict how Abeona Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Debt | -278.1 K | -292 K |
Pair Trading with Abeona Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abeona Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Abeona Stock
Moving against Abeona Stock
| 0.7 | IMRN | Immuron Ltd ADR | PairCorr |
| 0.56 | EVGN | Evogene | PairCorr |
| 0.54 | GNLX | Genelux Common | PairCorr |
| 0.47 | EDIT | Editas Medicine Earnings Call This Week | PairCorr |
| 0.47 | QSI | QuantumSi | PairCorr |
The ability to find closely correlated positions to Abeona Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abeona Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abeona Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abeona Therapeutics to buy it.
The correlation of Abeona Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abeona Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abeona Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abeona Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Abeona Therapeutics Correlation against competitors. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Will Biotechnology sector continue expanding? Could Abeona diversify its offerings? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Abeona Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 1.21 | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets | Return On Equity |
Investors evaluate Abeona Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Abeona Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Abeona Therapeutics' market price to deviate significantly from intrinsic value.
Understanding that Abeona Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Abeona Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Abeona Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.